Concepts (217)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Myocardial Revascularization | 4 | 2019 | 267 | 1.56 | Why? |
| Myocardial Ischemia | 4 | 2018 | 781 | 1.28 | Why? |
| Shock, Cardiogenic | 7 | 2019 | 700 | 1.04 | Why? |
| Cardiovascular Agents | 3 | 2018 | 663 | 1.01 | Why? |
| Cardiac Catheterization | 3 | 2018 | 882 | 0.94 | Why? |
| Comparative Effectiveness Research | 2 | 2018 | 178 | 0.85 | Why? |
| Sodium Chloride Symporter Inhibitors | 1 | 2020 | 45 | 0.85 | Why? |
| Endpoint Determination | 2 | 2018 | 344 | 0.78 | Why? |
| Myocardial Infarction | 11 | 2020 | 3361 | 0.77 | Why? |
| Faith Healing | 1 | 2018 | 13 | 0.75 | Why? |
| Adrenergic beta-Antagonists | 2 | 2020 | 465 | 0.73 | Why? |
| Calcium Channel Blockers | 1 | 2020 | 367 | 0.64 | Why? |
| Cardiologists | 1 | 2020 | 366 | 0.59 | Why? |
| Conservative Treatment | 1 | 2018 | 349 | 0.58 | Why? |
| Randomized Controlled Trials as Topic | 6 | 2020 | 10649 | 0.53 | Why? |
| Physician's Role | 1 | 2020 | 853 | 0.45 | Why? |
| Aortic Valve | 1 | 2017 | 664 | 0.43 | Why? |
| Plaque, Atherosclerotic | 4 | 2017 | 423 | 0.36 | Why? |
| Transcatheter Aortic Valve Replacement | 1 | 2017 | 839 | 0.36 | Why? |
| Patient Readmission | 1 | 2017 | 1543 | 0.35 | Why? |
| Cardiology | 3 | 2019 | 2873 | 0.35 | Why? |
| Coronary Artery Disease | 3 | 2017 | 2570 | 0.34 | Why? |
| Angiotensin Receptor Antagonists | 2 | 2020 | 3892 | 0.30 | Why? |
| Anticoagulants | 3 | 2021 | 9563 | 0.29 | Why? |
| Benzaldehydes | 3 | 2017 | 27 | 0.27 | Why? |
| Oximes | 3 | 2017 | 51 | 0.26 | Why? |
| Biomedical Research | 3 | 2019 | 5270 | 0.26 | Why? |
| ST Elevation Myocardial Infarction | 1 | 2020 | 3051 | 0.26 | Why? |
| Ventricular Dysfunction, Right | 2 | 2017 | 639 | 0.25 | Why? |
| Research Design | 2 | 2018 | 5830 | 0.24 | Why? |
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2020 | 5277 | 0.23 | Why? |
| Coronary Disease | 2 | 2017 | 645 | 0.22 | Why? |
| Patient Discharge | 1 | 2017 | 5696 | 0.22 | Why? |
| Percutaneous Coronary Intervention | 1 | 2017 | 3646 | 0.21 | Why? |
| Foundations | 2 | 2018 | 88 | 0.20 | Why? |
| Healthcare Disparities | 1 | 2017 | 3893 | 0.19 | Why? |
| Coronary Angiography | 3 | 2020 | 2275 | 0.19 | Why? |
| National Heart, Lung, and Blood Institute (U.S.) | 1 | 2018 | 56 | 0.19 | Why? |
| Mean Platelet Volume | 1 | 2020 | 203 | 0.19 | Why? |
| Thrombosis | 4 | 2021 | 7504 | 0.18 | Why? |
| Arginine | 2 | 2014 | 377 | 0.18 | Why? |
| Heparin | 2 | 2021 | 2600 | 0.18 | Why? |
| Hospitals | 1 | 2017 | 11793 | 0.17 | Why? |
| Platelet Aggregation | 1 | 2019 | 318 | 0.16 | Why? |
| Eligibility Determination | 1 | 2018 | 255 | 0.16 | Why? |
| Longevity | 1 | 2018 | 159 | 0.16 | Why? |
| Ventricular Dysfunction, Left | 2 | 2014 | 993 | 0.16 | Why? |
| Sample Size | 1 | 2018 | 518 | 0.15 | Why? |
| Physical Exertion | 1 | 2017 | 176 | 0.15 | Why? |
| Odds Ratio | 4 | 2021 | 5861 | 0.15 | Why? |
| Hemodynamics | 3 | 2017 | 1562 | 0.15 | Why? |
| Patient Selection | 2 | 2020 | 4560 | 0.14 | Why? |
| C-Reactive Protein | 3 | 2021 | 7972 | 0.14 | Why? |
| Rheumatic Fever | 1 | 2014 | 36 | 0.14 | Why? |
| Chi-Square Distribution | 1 | 2017 | 961 | 0.14 | Why? |
| Sexism | 1 | 2018 | 278 | 0.13 | Why? |
| Research Support as Topic | 1 | 2018 | 327 | 0.13 | Why? |
| Multivariate Analysis | 4 | 2019 | 5440 | 0.13 | Why? |
| Career Choice | 1 | 2019 | 498 | 0.13 | Why? |
| History, 20th Century | 1 | 2019 | 1282 | 0.12 | Why? |
| Mindfulness | 1 | 2018 | 437 | 0.12 | Why? |
| Mineralocorticoid Receptor Antagonists | 1 | 2014 | 203 | 0.12 | Why? |
| New York | 1 | 2020 | 2488 | 0.12 | Why? |
| Anxiety | 1 | 2018 | 17311 | 0.12 | Why? |
| Treatment Outcome | 9 | 2018 | 51732 | 0.11 | Why? |
| Coronary Vasospasm | 1 | 2011 | 36 | 0.11 | Why? |
| Diagnostic Techniques, Cardiovascular | 1 | 2012 | 144 | 0.11 | Why? |
| Renin-Angiotensin System | 2 | 2020 | 3661 | 0.11 | Why? |
| History, 21st Century | 1 | 2019 | 1849 | 0.11 | Why? |
| Propensity Score | 1 | 2020 | 2690 | 0.11 | Why? |
| Multicenter Studies as Topic | 1 | 2018 | 2437 | 0.11 | Why? |
| Interdisciplinary Communication | 1 | 2019 | 1425 | 0.11 | Why? |
| Troponin | 1 | 2017 | 1058 | 0.11 | Why? |
| Cooperative Behavior | 1 | 2019 | 1216 | 0.11 | Why? |
| American Heart Association | 1 | 2012 | 347 | 0.11 | Why? |
| Bayes Theorem | 1 | 2020 | 3237 | 0.10 | Why? |
| Embolism | 1 | 2011 | 136 | 0.10 | Why? |
| Psychometrics | 1 | 2017 | 1269 | 0.10 | Why? |
| Antihypertensive Agents | 2 | 2020 | 1962 | 0.10 | Why? |
| Humans | 35 | 2021 | 930598 | 0.10 | Why? |
| Ischemia | 1 | 2018 | 901 | 0.10 | Why? |
| Registries | 3 | 2017 | 12327 | 0.10 | Why? |
| Hypothermia, Induced | 1 | 2012 | 176 | 0.10 | Why? |
| Heart Valve Diseases | 1 | 2014 | 355 | 0.10 | Why? |
| Interleukin-6 | 2 | 2017 | 7522 | 0.10 | Why? |
| Inflammation Mediators | 2 | 2017 | 2654 | 0.10 | Why? |
| Time Factors | 5 | 2018 | 31397 | 0.09 | Why? |
| Aged | 16 | 2021 | 215776 | 0.09 | Why? |
| Phospholipase A2 Inhibitors | 2 | 2017 | 26 | 0.09 | Why? |
| Heart Valve Prosthesis Implantation | 1 | 2014 | 552 | 0.09 | Why? |
| Research Personnel | 1 | 2018 | 1037 | 0.09 | Why? |
| Exercise Test | 1 | 2014 | 911 | 0.08 | Why? |
| Blood Platelets | 1 | 2019 | 1704 | 0.08 | Why? |
| Cardiovascular Diseases | 3 | 2019 | 11497 | 0.08 | Why? |
| Fibrin Fibrinogen Degradation Products | 2 | 2021 | 5993 | 0.08 | Why? |
| Coronary Occlusion | 1 | 2009 | 138 | 0.08 | Why? |
| Biomarkers | 6 | 2021 | 23361 | 0.08 | Why? |
| Patient Care Team | 2 | 2019 | 3556 | 0.08 | Why? |
| Risk Factors | 7 | 2021 | 71621 | 0.08 | Why? |
| Ultrasonography, Interventional | 1 | 2011 | 560 | 0.08 | Why? |
| Female | 19 | 2021 | 380317 | 0.08 | Why? |
| Logistic Models | 2 | 2021 | 9089 | 0.08 | Why? |
| Thrombolytic Therapy | 1 | 2018 | 2218 | 0.08 | Why? |
| Monocytes | 1 | 2019 | 2978 | 0.08 | Why? |
| Male | 18 | 2021 | 367725 | 0.07 | Why? |
| Electrophysiologic Techniques, Cardiac | 1 | 2009 | 396 | 0.07 | Why? |
| Leadership | 1 | 2019 | 2241 | 0.07 | Why? |
| Angioplasty, Balloon, Coronary | 1 | 2009 | 365 | 0.07 | Why? |
| Takotsubo Cardiomyopathy | 1 | 2011 | 453 | 0.07 | Why? |
| Anxiety Disorders | 1 | 2018 | 2290 | 0.07 | Why? |
| Middle Aged | 14 | 2021 | 270681 | 0.07 | Why? |
| Pneumonia, Viral | 4 | 2020 | 243684 | 0.07 | Why? |
| United States | 8 | 2020 | 46150 | 0.07 | Why? |
| Acute Coronary Syndrome | 1 | 2017 | 2107 | 0.07 | Why? |
| Heart Diseases | 1 | 2020 | 3503 | 0.06 | Why? |
| Coronavirus Infections | 3 | 2020 | 253789 | 0.06 | Why? |
| Decision Making | 1 | 2017 | 3132 | 0.06 | Why? |
| Evidence-Based Medicine | 2 | 2014 | 3228 | 0.06 | Why? |
| Risk Assessment | 4 | 2021 | 25439 | 0.06 | Why? |
| Attitude of Health Personnel | 1 | 2020 | 4741 | 0.06 | Why? |
| Venous Thromboembolism | 1 | 2020 | 4273 | 0.06 | Why? |
| Thromboxane B2 | 1 | 2020 | 23 | 0.05 | Why? |
| Practice Guidelines as Topic | 2 | 2018 | 15421 | 0.05 | Why? |
| Nitric Oxide | 1 | 2007 | 769 | 0.05 | Why? |
| CD40 Antigens | 1 | 2020 | 118 | 0.05 | Why? |
| Electrocardiography | 2 | 2011 | 3957 | 0.05 | Why? |
| Respiratory Tract Infections | 1 | 2020 | 6817 | 0.05 | Why? |
| Integrin beta3 | 1 | 2019 | 35 | 0.05 | Why? |
| Prognosis | 2 | 2020 | 32490 | 0.05 | Why? |
| P-Selectin | 1 | 2020 | 224 | 0.05 | Why? |
| Hemorrhage | 2 | 2021 | 3013 | 0.05 | Why? |
| Hypertension | 1 | 2020 | 8895 | 0.04 | Why? |
| Actigraphy | 1 | 2018 | 102 | 0.04 | Why? |
| Kaplan-Meier Estimate | 2 | 2017 | 4260 | 0.04 | Why? |
| Hospital Mortality | 4 | 2021 | 22087 | 0.04 | Why? |
| Exercise | 1 | 2017 | 6771 | 0.04 | Why? |
| Comorbidity | 2 | 2021 | 34796 | 0.04 | Why? |
| Heart Failure | 2 | 2017 | 6638 | 0.04 | Why? |
| Lipopolysaccharide Receptors | 1 | 2019 | 357 | 0.04 | Why? |
| Meditation | 1 | 2018 | 140 | 0.04 | Why? |
| Age Factors | 1 | 2017 | 21039 | 0.04 | Why? |
| Adult | 6 | 2021 | 244371 | 0.04 | Why? |
| Hospitalization | 3 | 2021 | 54280 | 0.04 | Why? |
| Treatment Failure | 1 | 2021 | 2106 | 0.04 | Why? |
| Proportional Hazards Models | 2 | 2017 | 6543 | 0.04 | Why? |
| Mitral Valve Stenosis | 1 | 2014 | 29 | 0.03 | Why? |
| Platelet Activation | 1 | 2019 | 660 | 0.03 | Why? |
| Magnetic Resonance Imaging | 1 | 2011 | 6551 | 0.03 | Why? |
| Stress, Psychological | 1 | 2018 | 10231 | 0.03 | Why? |
| Prospective Studies | 3 | 2017 | 43301 | 0.03 | Why? |
| Double-Blind Method | 2 | 2017 | 5988 | 0.03 | Why? |
| Hemoglobins | 1 | 2020 | 958 | 0.03 | Why? |
| Platelet Count | 1 | 2020 | 1381 | 0.03 | Why? |
| Peripheral Arterial Disease | 1 | 2019 | 471 | 0.03 | Why? |
| Severity of Illness Index | 2 | 2018 | 48226 | 0.03 | Why? |
| Aortic Valve Insufficiency | 1 | 2014 | 136 | 0.03 | Why? |
| Disease-Free Survival | 1 | 2017 | 1654 | 0.03 | Why? |
| Troponin I | 1 | 2021 | 1298 | 0.03 | Why? |
| Heparin, Low-Molecular-Weight | 1 | 2021 | 1731 | 0.03 | Why? |
| Vasodilator Agents | 1 | 2014 | 344 | 0.03 | Why? |
| Heart | 1 | 2020 | 1791 | 0.03 | Why? |
| Streptococcal Infections | 1 | 2014 | 255 | 0.03 | Why? |
| Peer Review | 1 | 2012 | 204 | 0.03 | Why? |
| Aspirin | 1 | 2019 | 1043 | 0.03 | Why? |
| Patient Acuity | 1 | 2017 | 1755 | 0.03 | Why? |
| Risk Reduction Behavior | 1 | 2017 | 946 | 0.03 | Why? |
| Coronary Vessels | 1 | 2017 | 914 | 0.03 | Why? |
| Mitral Valve Insufficiency | 1 | 2014 | 302 | 0.02 | Why? |
| Pharyngitis | 1 | 2014 | 687 | 0.02 | Why? |
| Secondary Prevention | 1 | 2014 | 762 | 0.02 | Why? |
| Follow-Up Studies | 2 | 2017 | 17020 | 0.02 | Why? |
| Ornithine | 1 | 2007 | 5 | 0.02 | Why? |
| Lymphocyte Count | 1 | 2020 | 4758 | 0.02 | Why? |
| Citrulline | 1 | 2007 | 36 | 0.02 | Why? |
| Congresses as Topic | 1 | 2018 | 1347 | 0.02 | Why? |
| Dose-Response Relationship, Drug | 1 | 2017 | 3776 | 0.02 | Why? |
| Survival Analysis | 1 | 2021 | 7592 | 0.02 | Why? |
| Quality Assurance, Health Care | 1 | 2012 | 596 | 0.02 | Why? |
| Phenotype | 1 | 2019 | 4037 | 0.02 | Why? |
| Death, Sudden | 1 | 2009 | 160 | 0.02 | Why? |
| Aged, 80 and over | 1 | 2017 | 88759 | 0.02 | Why? |
| Methylation | 1 | 2007 | 332 | 0.02 | Why? |
| Diagnosis, Differential | 1 | 2020 | 7220 | 0.02 | Why? |
| Aortic Valve Stenosis | 1 | 2014 | 741 | 0.02 | Why? |
| Betacoronavirus | 2 | 2020 | 204454 | 0.02 | Why? |
| Self Report | 1 | 2017 | 3802 | 0.02 | Why? |
| Sleep | 1 | 2018 | 2695 | 0.02 | Why? |
| Oxidation-Reduction | 1 | 2007 | 540 | 0.02 | Why? |
| Heart Defects, Congenital | 1 | 2014 | 933 | 0.02 | Why? |
| Pandemics | 3 | 2020 | 389249 | 0.02 | Why? |
| Retrospective Studies | 3 | 2021 | 105322 | 0.02 | Why? |
| International Cooperation | 1 | 2017 | 3436 | 0.02 | Why? |
| Incidence | 2 | 2017 | 25622 | 0.02 | Why? |
| Social Support | 1 | 2018 | 3183 | 0.02 | Why? |
| Cause of Death | 1 | 2017 | 4823 | 0.02 | Why? |
| Survival Rate | 1 | 2017 | 9206 | 0.02 | Why? |
| Emergencies | 1 | 2017 | 4095 | 0.01 | Why? |
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2014 | 1510 | 0.01 | Why? |
| Reproducibility of Results | 1 | 2019 | 11304 | 0.01 | Why? |
| Stents | 1 | 2009 | 916 | 0.01 | Why? |
| Mortality | 1 | 2017 | 7132 | 0.01 | Why? |
| Sex Factors | 1 | 2017 | 11014 | 0.01 | Why? |
| Echocardiography | 1 | 2014 | 3661 | 0.01 | Why? |
| Case-Control Studies | 1 | 2019 | 17671 | 0.01 | Why? |
| Heart Rate | 1 | 2009 | 1527 | 0.01 | Why? |
| Disease Progression | 1 | 2017 | 13580 | 0.01 | Why? |
| Referral and Consultation | 1 | 2014 | 4816 | 0.01 | Why? |
| Critical Illness | 1 | 2021 | 17281 | 0.01 | Why? |
| Oxidative Stress | 1 | 2007 | 2050 | 0.01 | Why? |
| Inflammation | 1 | 2019 | 13255 | 0.01 | Why? |
| Respiration, Artificial | 1 | 2021 | 22116 | 0.01 | Why? |
| Disease Management | 1 | 2014 | 6841 | 0.01 | Why? |
| Stroke | 1 | 2017 | 8839 | 0.01 | Why? |
| Predictive Value of Tests | 1 | 2007 | 9537 | 0.01 | Why? |
| Adolescent | 1 | 2021 | 86841 | 0.01 | Why? |
| Neoplasms | 1 | 2017 | 17251 | 0.01 | Why? |
| Animals | 1 | 2012 | 78931 | 0.00 | Why? |
Hochman's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(217)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(263)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_